Does rosmarinic acid underestimate as an experimental cardiovascular drug?

Detalhes bibliográficos
Autor(a) principal: Ferreira,Luciana Garros
Data de Publicação: 2013
Outros Autores: Celotto,Andrea Carla, Capellini,Verena Kise, Albuquerque,Agnes Afrodite Sumarelli, Nadai,Tales Rubens de, Carvalho,Marco Tulio Menezes de, Evora,Paulo Roberto Barbosa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Acta Cirúrgica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502013001300016
Resumo: PURPOSE: The rationale of the present review is to analize the activity of Rosmarinus officinalis in the the cardiovascular system METHODS: A MEDLINE database search (from January 1970 to December 2011) using only rosmarinic acid as searched term. RESULTS: The references search revealed 509 references about rosmarinic acid in 40 years (the first reference is from 1970). There is a powerful prevalence of antioxidant and cancer studies. Other diseases are few cited, as inflammation, brain (Alzheimer and Parkinson disease) and, memory; allergy; diabetes; atherosclerosis, and; hypertension. It is necessary to consider the complete absence of studies on coronary artery disease, myocardial ischemia, heart failure or ischemia/reperfusion injury. CONCLUSION: Rosmarinic acid is underestimated as an experimental cardiovascular drug and deserves more attention.
id SBDPC-1_5e9f30d1cf2e14cab58fe9f95a3e18b8
oai_identifier_str oai:scielo:S0102-86502013001300016
network_acronym_str SBDPC-1
network_name_str Acta Cirúrgica Brasileira (Online)
repository_id_str
spelling Does rosmarinic acid underestimate as an experimental cardiovascular drug?Rosmarinus officinalisPolyphenolsCardiovascular diseasesPURPOSE: The rationale of the present review is to analize the activity of Rosmarinus officinalis in the the cardiovascular system METHODS: A MEDLINE database search (from January 1970 to December 2011) using only rosmarinic acid as searched term. RESULTS: The references search revealed 509 references about rosmarinic acid in 40 years (the first reference is from 1970). There is a powerful prevalence of antioxidant and cancer studies. Other diseases are few cited, as inflammation, brain (Alzheimer and Parkinson disease) and, memory; allergy; diabetes; atherosclerosis, and; hypertension. It is necessary to consider the complete absence of studies on coronary artery disease, myocardial ischemia, heart failure or ischemia/reperfusion injury. CONCLUSION: Rosmarinic acid is underestimated as an experimental cardiovascular drug and deserves more attention.Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502013001300016Acta Cirúrgica Brasileira v.28 suppl.1 2013reponame:Acta Cirúrgica Brasileira (Online)instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)instacron:SBDPC10.1590/S0102-86502013001300016info:eu-repo/semantics/openAccessFerreira,Luciana GarrosCelotto,Andrea CarlaCapellini,Verena KiseAlbuquerque,Agnes Afrodite SumarelliNadai,Tales Rubens deCarvalho,Marco Tulio Menezes deEvora,Paulo Roberto Barbosaeng2013-02-01T00:00:00Zoai:scielo:S0102-86502013001300016Revistahttps://www.bvs-vet.org.br/vetindex/periodicos/acta-cirurgica-brasileira/https://old.scielo.br/oai/scielo-oai.php||sgolden@terra.com.br0102-86501678-2674opendoar:2013-02-01T00:00Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)false
dc.title.none.fl_str_mv Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title Does rosmarinic acid underestimate as an experimental cardiovascular drug?
spellingShingle Does rosmarinic acid underestimate as an experimental cardiovascular drug?
Ferreira,Luciana Garros
Rosmarinus officinalis
Polyphenols
Cardiovascular diseases
title_short Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title_full Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title_fullStr Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title_full_unstemmed Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title_sort Does rosmarinic acid underestimate as an experimental cardiovascular drug?
author Ferreira,Luciana Garros
author_facet Ferreira,Luciana Garros
Celotto,Andrea Carla
Capellini,Verena Kise
Albuquerque,Agnes Afrodite Sumarelli
Nadai,Tales Rubens de
Carvalho,Marco Tulio Menezes de
Evora,Paulo Roberto Barbosa
author_role author
author2 Celotto,Andrea Carla
Capellini,Verena Kise
Albuquerque,Agnes Afrodite Sumarelli
Nadai,Tales Rubens de
Carvalho,Marco Tulio Menezes de
Evora,Paulo Roberto Barbosa
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ferreira,Luciana Garros
Celotto,Andrea Carla
Capellini,Verena Kise
Albuquerque,Agnes Afrodite Sumarelli
Nadai,Tales Rubens de
Carvalho,Marco Tulio Menezes de
Evora,Paulo Roberto Barbosa
dc.subject.por.fl_str_mv Rosmarinus officinalis
Polyphenols
Cardiovascular diseases
topic Rosmarinus officinalis
Polyphenols
Cardiovascular diseases
description PURPOSE: The rationale of the present review is to analize the activity of Rosmarinus officinalis in the the cardiovascular system METHODS: A MEDLINE database search (from January 1970 to December 2011) using only rosmarinic acid as searched term. RESULTS: The references search revealed 509 references about rosmarinic acid in 40 years (the first reference is from 1970). There is a powerful prevalence of antioxidant and cancer studies. Other diseases are few cited, as inflammation, brain (Alzheimer and Parkinson disease) and, memory; allergy; diabetes; atherosclerosis, and; hypertension. It is necessary to consider the complete absence of studies on coronary artery disease, myocardial ischemia, heart failure or ischemia/reperfusion injury. CONCLUSION: Rosmarinic acid is underestimated as an experimental cardiovascular drug and deserves more attention.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502013001300016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502013001300016
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0102-86502013001300016
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
publisher.none.fl_str_mv Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
dc.source.none.fl_str_mv Acta Cirúrgica Brasileira v.28 suppl.1 2013
reponame:Acta Cirúrgica Brasileira (Online)
instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron:SBDPC
instname_str Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron_str SBDPC
institution SBDPC
reponame_str Acta Cirúrgica Brasileira (Online)
collection Acta Cirúrgica Brasileira (Online)
repository.name.fl_str_mv Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
repository.mail.fl_str_mv ||sgolden@terra.com.br
_version_ 1752126442197483520

Registros relacionados